While neurovascular uses are well-known, 2025 has seen a massive expansion of liquid embolic agents into peripheral vascular applications. These agents are now a standard tool for treating venous malformations, varicoceles, and even complex arterial hemorrhages in the limbs. The ability of the liquid to conform to the tortuous and varied anatomy of the peripheral vessels makes it superior to traditional mechanical plugs. This versatility is allowing interventional radiologists to treat a wider range of vascular abnormalities through a single, 2mm puncture in the groin or wrist.

The diversification of clinical applications is a primary driver in the Liquid Embolic Market, as more vascular surgeons and interventionalists adopt these tools for non-neurological procedures. In 2025, specialized liquid agents with varying viscosities are being used to "tailor" the treatment to the specific flow rate of the target vessel. This high level of customization is leading to better functional results and fewer complications in the treatment of chronic vascular conditions.

FAQ

Q: What are peripheral vascular malformations? A: These are abnormal connections between arteries and veins in the body (outside the brain) that can cause pain, swelling, and skin changes.

Q: How is the liquid embolic delivered to the arms or legs? A: It is delivered through a thin microcatheter that is guided to the target area using real-time X-ray imaging.